Dr. Eric Albert Meier, MD

Dr. Meier practices at Allergy Asthma and Immunology Center of Alaska in Anchorage, Alaska.

Dr. Meier's NPI, 1720076656, was assigned on October 13, 2005. Dr. Meier graduated from University of Texas Southwestern Medical School at Dallas in 1997. Dr. Meier holds Alaska license 6004.

Dr. Meier's primary practice is Allergy Asthma and Immunology Center of Alaska, at 3841 Piper St, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-6228.

Dr. Meier's primary practice is Allergy Asthma and Immunology Center of Alaska in Anchorage, Alaska. Dr. Meier is also affiliated with Providence Alaska Medical Center. The medical group on file is Allergy, Asthma and Immunology Center of Alaska. Dmand AI also links Dr. Meier to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meier practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Meier's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Meier is licensed in Alaska.

CMS data shows 7,862 Medicare services from Dr. Meier across 16 procedure codes in 2024, for 227 Medicare patients. Medicare paid $199,141 for them. Every service was in an office.

CMS counts 227 Medicare patients who saw Dr. Meier in 2024. The largest group is 65 to 74, with 127 patients. 62% of them have asthma, and 61% have high cholesterol. 16% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meier's median patient age at 52, with 57% women.

In 2024, Dr. Meier wrote 320 Medicare Part D claims for 61 patients. 53% of them were for generic drugs. CMS names the drug for 222 of them, across 8 drugs with 11 or more claims each, at $157,382 in total drug cost. In 2023, CMS named 311 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 16 out of 100 for Dr. Meier for performance year 2024, reported individually. Dr. Meier accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Meier in 2015. Dr. Meier's most frequent co-authors are Jeffrey G. Demain, MD and Stephanie Anne Wolanin, MD.

CMS Open Payments shows 415 general payments to Dr. Meier from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $23,846.

Dr. Meier graduated from University of Texas Southwestern Medical School at Dallas in 1997.